Phosphodiesterase Type 5 Inhibitors and Selective Estrogen Receptor Modulators Can Prevent But Not Reverse Myofibroblast Transformation in Peyronie's DiseaseMarcus M. Ilg, Selim Cellek|The Journal of Sexual Medicine|2020Cited by 25